| Detected | Trial | Change |
|---|---|---|
| 2026-08-07 | NCT06456463 A Study of Tagraxofusp in Combination With Venetoclax and Azacitidine in Adults With… |
Enrollment closed, study ongoing |
| 2026-07-19 | NCT06638307 A First-in-Human Study of MEN2312 in Adults With Advanced Breast Cancer |
date change Primary completion pushed: 2026-06 -> 2027-10-24 |
| 2026-07-19 | NCT06638307 A First-in-Human Study of MEN2312 in Adults With Advanced Breast Cancer |
date change Completion pushed: 2026-10 -> 2029-10-23 |
| First Posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-08-14 | NCT07766018 A Phase 2 Bridging Study of Elacestrant Monotherapy in Advanced or Metastatic Breast… | Phase 2 | Recruiting |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 3 | |||
| NCT06492616 | A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2… | Breast Cancer | Recruiting |
| Phase 2 | |||
| NCT07766018 | A Phase 2 Bridging Study of Elacestrant Monotherapy in Advanced or Metastatic Breast… | ER+/HER2- Advanced or Metastatic Breast Cancer | Recruiting |
| NCT05596409 | ELACESTRANT in Women and Men With CDK4/6 Inhibitor-Naive Estrogen Receptor Positive… | Metastatic Breast Cancer | Active, Not Recruiting |
| NCT06456463 | A Study of Tagraxofusp in Combination With Venetoclax and Azacitidine in Adults With… | Acute Myeloid Leukemia | Active, Not Recruiting |
| Phase 1/2 | |||
| NCT05386108 | Study of Abemaciclib and Elacestrant in Participants With Brain Metastasis Due to… | Breast Neoplasms | Recruiting |
| NCT05563220 | Open-Label Umbrella Study To Evaluate Safety And Efficacy Of Elacestrant In Various… | Breast Cancer | Active, Not Recruiting |
| Phase 1 | |||
| NCT07226427 | A First-in-Human Study of MEN2501 in Participants With Platinum-Resistant Ovarian Cancer | Platinum-resistant Ovarian Cancer | Recruiting |
| NCT06638307 | A First-in-Human Study of MEN2312 in Adults With Advanced Breast Cancer | Advanced Breast Cancer | Recruiting |